Literature DB >> 26364720

The lncRNA MALAT1 protects the endothelium against ox-LDL-induced dysfunction via upregulating the expression of the miR-22-3p target genes CXCR2 and AKT.

Yong Tang1, Xian Jin2, Yin Xiang1, Yu Chen3, Cheng-xing Shen1, Ya-chen Zhang4, Yi-gang Li5.   

Abstract

CXCR2 plays a key role in protecting the integrity of the endothelium. Emerging evidence has demonstrated that the long ncRNAs (lncRNA) Human metastasis associated lung adenocarcinoma transcript 1 (MALAT1) participates in the regulation of the pathophysiological processes. However, whether there is crosstalk between CXCR2 and MALAT1 remains unknown. In this study, we demonstrated that MALAT1 was upregulated in patients with unstable angina. MALAT1 silencing significantly downregulated the expression of the miR-22-3p target gene CXCR2 via reversing the effect of the miR-22-3p, resulting in the aggravation of Oxidized low-density lipoprotein (ox-LDL)-induced endothelial injury; this process was associated with the AKT pathway. Thus, MALAT1 protects the endothelium from ox-LDL-induced endothelial dysfunction partly through competing with miR-22-3p for endogenous RNA.
Copyright © 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CXCR2; Endothelial cells; MALAT1; miRNA-22-3p; ox-LDL

Mesh:

Substances:

Year:  2015        PMID: 26364720     DOI: 10.1016/j.febslet.2015.08.046

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  34 in total

Review 1.  LncRNAs in vascular biology and disease.

Authors:  Viorel Simion; Stefan Haemmig; Mark W Feinberg
Journal:  Vascul Pharmacol       Date:  2018-02-06       Impact factor: 5.773

2.  Inhibition of LncRNA MALAT1 Attenuates Cerebral Ischemic Reperfusion Injury via Regulating AQP4 Expression.

Authors:  Jing Jin; Hongwei Wang; Xiaoxiao Zheng; Shangzhi Xie; Li Zheng; Renya Zhan
Journal:  Eur Neurol       Date:  2020-10-30       Impact factor: 1.710

3.  MicroRNA-33-5p inhibits cholesterol efflux in vascular endothelial cells by regulating citrate synthase and ATP-binding cassette transporter A1.

Authors:  Qiong Xie; Jianqiang Peng; Ying Guo; Feng Li
Journal:  BMC Cardiovasc Disord       Date:  2021-09-13       Impact factor: 2.298

Review 4.  Long non-coding RNAs and cell death following ischemic stroke.

Authors:  Masoumeh Alishahi; Farhoodeh Ghaedrahmati; Tannaz Akbari Kolagar; William Winlow; Negin Nikkar; Maryam Farzaneh; Seyed Esmaeil Khoshnam
Journal:  Metab Brain Dis       Date:  2019-05-04       Impact factor: 3.584

Review 5.  Non-coding RNA regulation of endothelial and macrophage functions during atherosclerosis.

Authors:  Binod Aryal; Yajaira Suárez
Journal:  Vascul Pharmacol       Date:  2018-03-15       Impact factor: 5.773

6.  TUSC7 acts as a tumor suppressor in colorectal cancer.

Authors:  Weidan Ren; Shuo Chen; Guiwei Liu; Xuesong Wang; Haopeng Ye; Yanguo Xi
Journal:  Am J Transl Res       Date:  2017-09-15       Impact factor: 4.060

Review 7.  Regulatory Non-coding RNAs in Atherosclerosis.

Authors:  Andreas Schober; Saffiyeh Saboor Maleki; Maliheh Nazari-Jahantigh
Journal:  Handb Exp Pharmacol       Date:  2022

8.  Long non-coding RNA NORAD induces phenotypic regulation of vascular smooth muscle cells through regulating microRNA-136-5p-targeted KDM1A.

Authors:  Chao Lv; Jun Wang; Shuhui Dai; Yanwei Chen; Xiaofan Jiang; Xia Li
Journal:  Cell Cycle       Date:  2021-09-29       Impact factor: 5.173

9.  Long noncoding RNA uc003pxg.1 regulates endothelial cell proliferation and migration via miR‑25‑5p in coronary artery disease.

Authors:  Ping Li; Yuan Li; Lu Chen; Xuexing Ma; Xinxin Yan; Meina Yan; Buyun Qian; Feng Wang; Jingyi Xu; Juan Yin; Guidong Xu; Kangyun Sun
Journal:  Int J Mol Med       Date:  2021-07-02       Impact factor: 4.101

Review 10.  Crosstalk between Long Noncoding RNAs and MicroRNAs in Health and Disease.

Authors:  Ahmed S Bayoumi; Amer Sayed; Zuzana Broskova; Jian-Peng Teoh; James Wilson; Huabo Su; Yao-Liang Tang; Il-Man Kim
Journal:  Int J Mol Sci       Date:  2016-03-11       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.